A Disability Critique of the New Prenatal Test for Down Syndrome
A Disability Critique of the New Prenatal Test for Down Syndrome
复制标题
DOI：
10.1353/ken.2013.0017
复制
发表时间：
2013-12-01
影响因子：
1.4
通讯作者：
Kaposy, Chris
中科院分区：
文献类型：
--
作者：
Kaposy, Chris
这篇文章提供了证据，证明一种新的唐氏综合征无创检测（称为“MaterniT21”）的可用性可能导致唐氏综合征产前检测的增加和患病胎儿选择性流产的增加。我认为，唐氏综合症患者和同情他们的人有理由反对这些发展，因为对认知残疾的偏见会影响唐氏综合症检测和终止的决定，而由偏见驱动的社会实践是令人反感的。这篇文章提出了许多对残疾批判的挑战，这些批评是由批评者提出的。我讨论了对残疾的批评是否等同于反对产前检查的“表现主义者”，唐氏综合症患者所经历的伤害的本质，以及产前检查与这种伤害之间的联系。
This article presents evidence that the availability of a new noninvasive test for Down syndrome (known as "MaterniT21") could result in increased uptake of prenatal testing for Down syndrome and an increase in selective abortions of affected fetuses. I argue that people with Down syndrome and those sympathetic to them have reason to object to these developments because bias against cognitive disability is an influence on decisions to test and terminate for Down syndrome, and social practices motivated by bias are objectionable. The article addresses many of the challenges to the disability critique formulated by its detractors. I discuss whether the disability critique is the same as the "expressivist" objection to prenatal testing, the nature of the harm experienced by people with Down syndrome, and the link between prenatal testing and this harm.